Cathepsin Activatable Fluorescent Probe

NCT01626066 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Soft Tissue Sarcoma
Breast Cancer

Interventions

DRUG: LUM015

Sponsor

David Kirsch

Collaborators

[object Object]